Production (Stage)
Universal Ibogaine Inc.
IBOGF
$0.018
-$0.0003-1.64%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.60K | -214.20K | -253.90K | -554.40K | -635.50K |
| Total Depreciation and Amortization | 56.60K | 62.70K | 58.90K | 71.10K | 59.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.80K | 2.10K | 5.70K | 507.80K | 274.30K |
| Change in Net Operating Assets | -91.40K | 7.50K | 9.10K | -86.60K | -67.40K |
| Cash from Operations | -77.70K | -141.80K | -180.10K | -62.00K | -369.40K |
| Capital Expenditure | -- | -- | -800.00 | -14.30K | -14.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -800.00 | -14.30K | -14.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -32.50K | -32.00K | -32.00K | -122.00K | -32.70K |
| Issuance of Common Stock | -- | -- | -- | 220.00K | 992.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.50K | 415.80K | -- | -92.70K | -334.00K |
| Cash from Financing | -25.30K | 270.10K | -23.40K | 3.80K | 461.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.90K | 128.20K | -204.30K | -72.50K | 77.80K |